Literature DB >> 24401765

Effects of prochlorperazine on normal vestibular ocular and perceptual responses: a randomised, double-blind, crossover, placebo-controlled study.

M Patel1, Y Nigmatullina, B M Seemungal, J F Golding, A M Bronstein.   

Abstract

BACKGROUND: The present study investigated whether prochlorperazine affects vestibulo-ocular reflex (VOR) and vestibulo-perceptual function.
METHODS: We studied 12 healthy naïve subjects 3 h after a single dose of oral prochlorperazine 5 mg in a randomised, placebo-controlled, double-blind, crossover study in healthy young subjects. Two rotational tests in yaw were used: (1) a threshold task investigating perceptual motion detection and nystagmic thresholds (acceleration steps of 0.5°/s(2)) and (2) suprathreshold responses to velocity steps of 90°/s in which vestibulo-ocular and vestibuloperceptual time constants of decay, as well as VOR gain, were measured.
RESULTS: Prochlorperazine had no effect upon any measure of nystagmic or perceptual vestibular function compared to placebo. This lack of effects on vestibular-mediated motion perception suggests that the drug is likely to act more as an anti-emetic than as an antivertiginous agent.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24401765     DOI: 10.1159/000357028

Source DB:  PubMed          Journal:  Audiol Neurootol        ISSN: 1420-3030            Impact factor:   1.854


  3 in total

Review 1.  Vestibular Precision at the Level of Perception, Eye Movements, Posture, and Neurons.

Authors:  Ana Diaz-Artiles; Faisal Karmali
Journal:  Neuroscience       Date:  2021-06-02       Impact factor: 3.708

2.  Predictors of clinical recovery from vestibular neuritis: a prospective study.

Authors:  Sian Cousins; Diego Kaski; Nicholas Cutfield; Qadeer Arshad; Hena Ahmad; Michael A Gresty; Barry M Seemungal; John Golding; Adolfo M Bronstein
Journal:  Ann Clin Transl Neurol       Date:  2017-03-22       Impact factor: 4.511

3.  Effects of Betahistine on Vestibulo-Ocular Reflex in Normal Healthy Adults: A Randomized Double-Blind, Placebo-Controlled Trial.

Authors:  Wan Ahmad Amiruddin Wan Hassan; Khairul Ridhwan Mohd Nasir Mohd Nasir; Saiful Adli Jamaluddin; Edre Mohammad Aidid; Yahia F Hussein Al-Hadeethi
Journal:  Cureus       Date:  2022-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.